Top

Published in:

01-04-2017

Commercially available lifestyle modification program: randomized controlled trial addressing heart and bone health in BRCA1/2+ breast cancer survivors after risk-reducing salpingo-oophorectomy

Authors: Kathleen M. Sturgeon, Lorraine T. Dean, Mariane Heroux, Jessica Kane, Toni Bauer, Erica Palmer, Jin Long, Shannon Lynch, Linda Jacobs, David B. Sarwer, Mary B. Leonard, Kathryn Schmitz

Published in: Journal of Cancer Survivorship | Issue 2/2017

Abstract

Purpose

The goal of this RCT was to examine the efficacy and safety of a web-based program to improve cardiovascular and bone health outcomes, among 35 BRCA1/2+ breast cancer survivors who underwent prophylactic oophorectomy and thus experienced premature surgical menopause.

Methods

A 12-month commercially available web-based lifestyle modification program (Precision Nutrition Coaching) was utilized. Cardiovascular fitness, dietary intake, leisure time activity, body composition, bone mineral density, bone structure, and muscle strength were assessed.

Results

Average adherence to all program components was 74.8 %. Women in the intervention group maintained their cardiovascular fitness level over the 12 months (1.1 ± 7.9 %), while the control group significantly decreased fitness capacity (−4.0 ± 7.5 %). There was a significant difference between groups in percent change of whole body bone area (−0.8 ± 2.5 control and 0.5 ± 1.30 intervention). We also observed decreased BMI (−4.7 ± 6.2 %) and fat mass (−8.6 ± 12.7 %) in the intervention group due to significant concomitant decreases in caloric intake and increases in caloric expenditure. The control group demonstrated decreased caloric intake and decreased lean tissue mass.

Conclusions

In this population at high risk for detrimental cardiovascular and bone outcomes, a commercially available lifestyle intervention program mitigated a decline in cardiovascular health, improved bone health, and decreased weight through fat loss.

Implications for cancer survivors

Precision Nutrition Coaching has shown benefit in breast cancer survivors for reduced risk of deleterious cardiovascular and bone outcomes.

Jones LW, Haykowsky MJ, Swartz JJ, Douglas PS, Mackey JR. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol. 2007;50(15):1435–41.CrossRefPubMed

Khan NF, Mant D, Carpenter L, Forman D, Rose PW. Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study. Br J Cancer. 2011;105(Suppl 1):S29–37. doi:10.1038/bjc.2011.420.CrossRefPubMedPubMedCentral

Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res. 2011;13(3):R64. doi:10.1186/bcr2901.CrossRefPubMedPubMedCentral

Campeau PM, Foulkes WD, Tischkowitz MD. Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet. 2008;124(1):31–42. doi:10.1007/s00439-008-0529-1.CrossRefPubMed

Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H, et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer. 2005;104(12):2807–16. doi:10.1002/cncr.21536.CrossRefPubMed

Bordeleau L, Lipscombe L, Lubinski J, Ghadirian P, Foulkes WD, Neuhausen S, et al. Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations. Cancer. 2011;117(9):1812–8. doi:10.1002/cncr.25595.CrossRefPubMed

Mai PL, Chatterjee N, Hartge P, Tucker M, Brody L, Struewing JP, et al. Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma. PLoS One. 2009;4(3):e4812. doi:10.1371/journal.pone.0004812.CrossRefPubMedPubMedCentral

Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72(5):1117–30.CrossRefPubMedPubMedCentral

Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25(11):1329–33.CrossRefPubMedPubMedCentral

10.

Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, et al. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst. 1999;91(17):1475–9.CrossRefPubMed

11.

Rebbeck TR. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers. Eur J Cancer. 2002;38(Suppl 6):S15–7.CrossRefPubMed

12.

Kauff ND, Domchek SM, Friebel TM, Robson ME, Lee J, Garber JE, et al. Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J Clin Oncol. 2008;26(8):1331–7. doi:10.1200/JCO.2007.13.9626.CrossRefPubMedPubMedCentral

13.

Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton 3rd LJ. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol. 2006;7(10):821–8.CrossRefPubMed

14.

Michelsen TM, Pripp AH, Tonstad S, Trope CG, Dorum A. Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study. Eur J Cancer. 2009;45(1):82–9. doi:10.1016/j.ejca.2008.09.028.CrossRefPubMed

15.

Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause. 2006;13(2):265–79. doi:10.1097/01.gme.0000218683.97338.ea.CrossRefPubMed

16.

Lin X, Zhang X, Guo J, Roberts CK, McKenzie S, Wu WC, et al. Effects of exercise training on cardiorespiratory fitness and biomarkers of cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2015;4(7) doi:10.1161/JAHA.115.002014.

17.

Blair SN, Kampert JB, Kohl 3rd HW, Barlow CE, Macera CA, Paffenbarger Jr RS, et al. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA. 1996;276(3):205–10.CrossRefPubMed

18.

Vigen R, Ayers C, Willis B, DeFina L, Berry JD. Association of cardiorespiratory fitness with total, cardiovascular, and noncardiovascular mortality across 3 decades of follow-up in men and women. Circ Cardiovasc Qual Outcomes. 2012;5(3):358–64. doi:10.1161/CIRCOUTCOMES.111.963181.CrossRefPubMedPubMedCentral

19.

Roger VL, Jacobsen SJ, Pellikka PA, Miller TD, Bailey KR, Gersh BJ. Prognostic value of treadmill exercise testing: a population-based study in Olmsted County. Minnesota Circulation. 1998;98(25):2836–41.CrossRefPubMed

20.

Campbell KL, Van Patten CL, Neil SE, Kirkham AA, Gotay CC, Gelmon KA, et al. Feasibility of a lifestyle intervention on body weight and serum biomarkers in breast cancer survivors with overweight and obesity. J Acad Nutr Diet. 2012;112(4):559–67. doi:10.1016/j.jada.2011.10.022.CrossRefPubMed

21.

Hunter GR, Plaisance EP, Fisher G. Weight loss and bone mineral density. Curr Opin Endocrinol Diabetes Obes. 2014;21(5):358–62. doi:10.1097/MED.0000000000000087.CrossRefPubMedPubMedCentral

22.

Shah K, Armamento-Villareal R, Parimi N, Chode S, Sinacore DR, Hilton TN, et al. Exercise training in obese older adults prevents increase in bone turnover and attenuates decrease in hip bone mineral density induced by weight loss despite decline in bone-active hormones. J Bone Miner Res. 2011;26(12):2851–9. doi:10.1002/jbmr.475.CrossRefPubMedPubMedCentral

23.

Villareal DT, Chode S, Parimi N, Sinacore DR, Hilton T, Armamento-Villareal R, et al. Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med. 2011;364(13):1218–29. doi:10.1056/NEJMoa1008234.CrossRefPubMedPubMedCentral

24.

Schmitz KH, Williams NI, Kontos D, Kurzer MS, Schnall M, Domchek S, et al. Women In Steady Exercise Research (WISER) Sister: study design and methods. Contemp Clin Trials. 2015;41:17–30. doi:10.1016/j.cct.2014.12.016.CrossRefPubMed

25.

Lewis B, Williams D, Dunsiger S, Sciamanna C, Whiteley J, Napolitano M, et al. User attitudes towards physical activity websites in a randomized controlled trial. Prev Med. 2008;47(5):508–13. doi:10.1016/j.ypmed.2008.07.020.CrossRefPubMedPubMedCentral

26.

Vandelanotte C, Spathonis KM, Eakin EG, Owen N. Website-delivered physical activity interventions a review of the literature. Am J Prev Med. 2007;33(1):54–64.CrossRefPubMed

27.

Norman GJ, Zabinski MF, Adams MA, Rosenberg DE, Yaroch AL, Atienza AA. A review of eHealth interventions for physical activity and dietary behavior change. Am J Prev Med. 2007;33(4):336–45.CrossRefPubMedPubMedCentral

28.

Schmitz KH, Ahmed RL, Troxel A, Cheville A, Smith R, Lewis-Grant L, et al. Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med. 2009;361(7):664–73. doi:10.1056/NEJMoa0810118.CrossRefPubMed

29.

Schmitz KH, Hannan PJ, Stovitz SD, Bryan CJ, Warren M, Jensen MD. Strength training and adiposity in premenopausal women: strong, healthy, and empowered study. Am J Clin Nutr. 2007;86(3):566–72.PubMed

30.

Foster C, Jackson AS, Pollock ML, Taylor MM, Hare J, Sennett SM, et al. Generalized equations for predicting functional capacity from treadmill performance. Am Heart J. 1984;107(6):1229–34.CrossRefPubMed

31.

James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20. doi:10.1001/jama.2013.284427.CrossRefPubMed

32.

Gagnon JF, Sanschagrin F, Jacob S, Tremblay AA, Provencher L, Robert J, et al. Quantitative DNA methylation analysis of laser capture microdissected formalin-fixed and paraffin-embedded tissues. Exp Mol Pathol. 2010;88(1):184–9. doi:10.1016/j.yexmp.2009.09.020.CrossRefPubMed

33.

Tierney S, Aslam M, Rennie K, Grace P. Infrared optoelectronic volumetry, the ideal way to measure limb volume. Eur J Vasc Endovasc Surg. 1996;12(4):412–7.CrossRefPubMed

34.

Norman SA, Miller LT, Erikson HB, Norman MF, McCorkle R. Development and validation of a telephone questionnaire to characterize lymphedema in women treated for breast cancer. Phys Ther. 2001;81(6):1192–205.PubMed

35.

Powers SK, Sollanek KJ, Wiggs MP, Demirel HA, Smuder AJ. Exercise-induced improvements in myocardial antioxidant capacity: the antioxidant players and cardioprotection. Free Radic Res. 2014;48(1):43–51. doi:10.3109/10715762.2013.825371.CrossRefPubMed

36.

Powers SK, Ji LL, Leeuwenburgh C. Exercise training-induced alterations in skeletal muscle antioxidant capacity: a brief review. Med Sci Sports Exerc. 1999;31(7):987–97.CrossRefPubMed

37.

Cash SW, Beresford SA, Vaughan TL, Heagerty PJ, Bernstein L, White E, et al. Recent physical activity in relation to DNA damage and repair using the comet assay. J Phys Act Health. 2014;11(4):770–6. doi:10.1123/jpah.2012-0278.CrossRefPubMed

38.

Shukla PC, Singh KK, Quan A, Al-Omran M, Teoh H, Lovren F, et al. BRCA1 is an essential regulator of heart function and survival following myocardial infarction. Nat Commun. 2011;2:593. doi:10.1038/ncomms1601.CrossRefPubMedPubMedCentral

39.

Singh KK, Shukla PC, Quan A, Desjardins JF, Lovren F, Pan Y, et al. BRCA2 protein deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure. J Biol Chem. 2012;287(9):6604–14. doi:10.1074/jbc.M111.292664.CrossRefPubMed

40.

Fleg JL, Morrell CH, Bos AG, Brant LJ, Talbot LA, Wright JG, et al. Accelerated longitudinal decline of aerobic capacity in healthy older adults. Circulation. 2005;112(5):674–82.CrossRefPubMed

41.

Rivera CM, Grossardt BR, Rhodes DJ, Brown Jr RD, Roger VL, Melton 3rd LJ, et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause. 2009;16(1):15–23. doi:10.1097/gme.0b013e31818888f7.CrossRefPubMedPubMedCentral

42.

van Der Voort DJ, van Der Weijer PH, Barentsen R. Early menopause: increased fracture risk at older age. Osteoporos Int. 2003;14(6):525–30. doi:10.1007/s00198-003-1408-1.CrossRef

43.

Cohen JV, Chiel L, Boghossian L, Jones M, Stopfer JE, Powers J, et al. Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy. Familial Cancer. 2012;11(1):69–75. doi:10.1007/s10689-011-9480-8.CrossRefPubMed

44.

Kemmler W, Bebenek M, Kohl M, von Stengel S. Exercise and fractures in postmenopausal women. Final results of the controlled Erlangen Fitness and Osteoporosis Prevention Study (EFOPS). Osteoporos Int. 2015;26(10):2491–9. doi:10.1007/s00198-015-3165-3.CrossRefPubMed

45.

Reik W, Walter J. Genomic imprinting: parental influence on the genome. Nat Rev Genet. 2001;2(1):21–32. doi:10.1038/35047554.CrossRefPubMed

46.

Rock CL, Flatt SW, Byers TE, Colditz GA, Demark-Wahnefried W, Ganz PA, et al. Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: a behavioral weight loss intervention in overweight or obese breast cancer survivors. J Clin Oncol. 2015;33(28):3169–76. doi:10.1200/JCO.2015.61.1095.CrossRefPubMedPubMedCentral

47.

Wolin KY, Schwartz AL, Matthews CE, Courneya KS, Schmitz KH. Implementing the exercise guidelines for cancer survivors. The journal of supportive oncology. 2012;10(5):171–7. doi:10.1016/j.suponc.2012.02.001.CrossRefPubMedPubMedCentral

48.

Biro FM, Greenspan LC, Galvez MP. Puberty in girls of the 21st century. J Pediatr Adolesc Gynecol. 2012;25(5):289–94. doi:10.1016/j.jpag.2012.05.009.CrossRefPubMedPubMedCentral

Title: Commercially available lifestyle modification program: randomized controlled trial addressing heart and bone health in BRCA1/2+ breast cancer survivors after risk-reducing salpingo-oophorectomy
Authors: Kathleen M. Sturgeon
Lorraine T. Dean
Mariane Heroux
Jessica Kane
Toni Bauer
Erica Palmer
Jin Long
Shannon Lynch
Linda Jacobs
David B. Sarwer
Mary B. Leonard
Kathryn Schmitz
Publication date: 01-04-2017
Publisher: Springer US
Published in: Journal of Cancer Survivorship / Issue 2/2017
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-016-0582-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Implications for cancer survivors

Please log in to get access to this content

Other articles of this Issue 2/2017

Vaginal and sexual health treatment strategies within a female sexual medicine program for cancer patients and survivors

Preventive services use among female survivors of adolescent and young adult cancer

Non-graduation after comprehensive school, and early retirement but not unemployment are prominent in childhood cancer survivors—a Finnish registry-based study

Cardiovascular disease and physical activity in adult cancer survivors: a nested, retrospective study from the Atlantic PATH cohort

Patient-reported outcome measures of the impact of cancer on patients’ everyday lives: a systematic review

Posttraumatic stress disorder symptomatology in the course of allogeneic HSCT: a prospective study

Keynote webinar | Spotlight on antibody–drug conjugates in cancer